Rewrite your DNA: Currently, only 20 gene therapy products are available in the EU. High costs and a lack of regulatory harmonisation across Europe present barriers, while some forms of gene therapy present moral concerns. How can the EU promote research and translation of safe and accessible gene therapy to its citizens while balancing their moral dilemmas?